annb0t
Top 20
Opthea Limited
MELBOURNE, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Timothy E. Morris, the Companyâs Chief Financial Officer will present at the JMP Securities Life Sciences Conference being held in New York City on May 15-16 2023.
Mr.Morris will present on Tuesday, May 16th at 1:00 pm ET (3:00 am May...
>>> Read more: Opthea To Present at the JMP Securities Life Sciences Conference
MELBOURNE, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Timothy E. Morris, the Companyâs Chief Financial Officer will present at the JMP Securities Life Sciences Conference being held in New York City on May 15-16 2023.
Mr.Morris will present on Tuesday, May 16th at 1:00 pm ET (3:00 am May...
>>> Read more: Opthea To Present at the JMP Securities Life Sciences Conference
